AJP - Endo Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 281: E1122-E1127, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ngarmukos, C.
Right arrow Articles by Grekin, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ngarmukos, C.
Right arrow Articles by Grekin, R. J.
Vol. 281, Issue 6, E1122-E1127, December 2001

MINIREVIEW
Nontraditional aspects of aldosterone physiology

Chardpraorn Ngarmukos and Roger J. Grekin

Division of Endocrinology and Metabolism, Department of Internal Medicine, The University of Michigan, and The Veterans Administration Health System, Ann Arbor, Michigan 48105

Aldosterone is the most important circulating mineralocorticoid. It is secreted by the zona glomerulosa of the adrenal gland and plays a major role in sodium and potassium metabolism by binding to epithelial mineralocorticoid receptors (MR) in the renal collecting duct, promoting sodium resorption and potassium excretion. The action of aldosterone on its classic target epithelia has been extensively studied, and many of the signaling events that mediate its effects have been described. Recently, there has been increased interest in aldosterone actions on the cardiovascular system, which are mediated through nonclassical actions. These include local tissue production, nongenomic actions, and effects on nonepithelial targets. In this review article, we focus on the effects of aldosterone in nonepithelial tissues that are mediated through MR, especially cardiovascular effects.

aldosterone; cardiac fibrosis; hypertension; blood pressure; central nervous system


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
S. H. Lee, T.-H. Yoo, B.-Y. Nam, D. K. Kim, J. J. Li, D.-S. Jung, S.-J. Kwak, D.-R. Ryu, S. H. Han, J. E. Lee, et al.
Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions
Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1381 - F1390.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. H. Jeon, K.-y. Kim, J. H. Kim, A. Baek, H. Cho, Y. H. Lee, J. W. Kim, D. Kim, S. H. Han, J.-S. Lim, et al.
A novel adipokine CTRP1 stimulates aldosterone production
FASEB J, May 1, 2008; 22(5): 1502 - 1511.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. M. Mejia-Vilet, V. Ramirez, C. Cruz, N. Uribe, G. Gamba, and N. A. Bobadilla
Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F78 - F86.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. C. Aldigier, T. Kanjanbuch, L.-J. Ma, N. J. Brown, and A. B. Fogo
Regression of Existing Glomerulosclerosis by Inhibition of Aldosterone
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3306 - 3314.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. M. Perez-Rojas, S. Derive, J. A. Blanco, C. Cruz, L. M. de la Maza, G. Gamba, and N. A. Bobadilla
Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity
Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1020 - F1030.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. K. Rude, T.-A. S. Duhaney, G. M. Kuster, S. Judge, J. Heo, W. S. Colucci, D. A. Siwik, and F. Sam
Aldosterone Stimulates Matrix Metalloproteinases and Reactive Oxygen Species in Adult Rat Ventricular Cardiomyocytes
Hypertension, September 1, 2005; 46(3): 555 - 561.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. Saha, G. J. Eckert, W. T. Ambrosius, T.-Y. Chun, M. A. Wagner, Q. Zhao, and J. H. Pratt
Improvement in Blood Pressure With Inhibition of the Epithelial Sodium Channel in Blacks With Hypertension
Hypertension, September 1, 2005; 46(3): 481 - 487.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. G.A. Veliotes, A. J. Woodiwiss, D. A.J. Deftereos, D. Gray, O. Osadchii, and G. R. Norton
Aldosterone Receptor Blockade Prevents the Transition to Cardiac Pump Dysfunction Induced by {beta}-Adrenoreceptor Activation
Hypertension, May 1, 2005; 45(5): 914 - 920.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. Nithipatikom, B. B. Holmes, M. J. McCoy, C. J. Hillard, and W. B. Campbell
Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E820 - E827.
[Abstract] [Full Text] [PDF]

Home page
 Adv. Physiol. Educ.Home page
R. E. Booth, J. P. Johnson, and J. D. Stockand
ALDOSTERONE
Advan Physiol Educ, March 1, 2002; 26(1): 8 - 20.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online